Feb 9 |
Applied DNA Sciences, Inc. (APDN) Q1 2024 Earnings Call Transcript
|
Feb 9 |
Q1 2024 Applied DNA Sciences Inc Earnings Call
|
Feb 8 |
Applied DNA Sciences (APDN) Reports Q1 Loss, Tops Revenue Estimates
|
Feb 8 |
Applied DNA Sciences GAAP EPS of -$0.09 beats by $0.22, revenue of $0.89M beats by $0.11M
|
Feb 8 |
Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results
|
Feb 5 |
Applied DNA to Report First Quarter Fiscal 2024 Financial Results on Thursday, February 8, 2024
|
Feb 2 |
Applied DNA Announces Closing of $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
|
Jan 31 |
Applied DNA announces $3.44M registered direct offering
|
Jan 31 |
Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
|
Dec 14 |
Applied DNA Announces Joint Development Agreement to Integrate Linea(TM) IVT Platform into CDMO Kudo Biotechnology’s mRNA Manufacturing Workflow
|